Simply Wall St.
Heron Therapeutics, Inc. (NASDAQ:HRTX) is favoured by institutional owners who hold 57% of the company
📊
AI Sentiment
Positive
7/10
Heron Therapeutics Inc. News
Latest updates and market news for HRTX
1 news
Dec 14 - Dec 20, 2025
Page 1
Share this news page